January 2020 – Abstract of data to evaluate the predictive performance of established preterm birth biomarkers when combined with additional clinical and proteomic markers that will be presented at the Society for Maternal-Fetal Medicine’s 2020 Annual Meeting.  The study concluded that an established predictor, IBP4/SHBG, combined with novel factors demonstrated strong performance for predicting PTB and neonatal morbidity in an independent cohort.  Validation analyses on remaining study subjects are forthcoming and next-generation predictors like these may be valuable in risk assessment and management of pregnancy.

Abstract link #14